Janney Montgomery Scott LLC Sells 3,618 Shares of Chemed Corporation $CHE

Posted by Stanley Muller on Jul 11th, 2026

Janney Montgomery Scott LLC cut its stake in Chemed Corporation (NYSE:CHE – Free Report) by 48.1% during the first quarter, HoldingsChannel reports. The fund owned 3,900 shares of the company’s stock after selling 3,618 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Chemed were worth $1,473,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CHE. Geneos Wealth Management Inc. boosted its position in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in Chemed by 67.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after purchasing an additional 4,560 shares during the last quarter. Marshall Wace LLP bought a new position in Chemed in the second quarter worth about $579,000. Brown Advisory Inc. lifted its position in shares of Chemed by 36.9% during the second quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock valued at $267,000 after buying an additional 148 shares during the last quarter. Finally, Cerity Partners LLC lifted its position in shares of Chemed by 237.7% during the second quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock valued at $2,165,000 after buying an additional 3,133 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Stock Down 0.6%

Shares of CHE stock opened at $487.76 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $493.47. The stock’s 50-day simple moving average is $443.16 and its 200-day simple moving average is $428.70. The firm has a market capitalization of $6.47 billion, a PE ratio of 26.58, a P/E/G ratio of 1.81 and a beta of 0.52.

Chemed (NYSE:CHE – Get Free Report) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the prior year, the business earned $5.63 EPS. Chemed’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities analysts expect that Chemed Corporation will post 22.67 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of recent analyst reports. Royal Bank Of Canada raised their price target on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Finally, Bank of America raised their price objective on Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a research report on Thursday. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, Chemed currently has an average rating of “Hold” and an average price target of $480.25.

Get Our Latest Stock Analysis on CHE

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is owned by insiders.

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.